Allergy Diagnostics Market Segmentation by Product & Service (Assay Kits, Instruments, Services, and Consumables); by Tests (In-Vivo Tests and In-Vitro Tests); by Allergens (Inhaled Allergens, Food Allergens, Drug Allergens, and Others); and by End-Users (Diagnostic Laboratories, Hospital-Based Laboratories, Academic Research Institutes, and Others)-Global Demand Analysis & Opportunity Outlook 2031
Product Code: RP-ID-10070617 |
Published Date: 21 Mar 2025 |
Region: Global |
Category: Healthcare & Pharmaceuticals |
Report ID: 10070617
Market Overview:
Allergy Diagnostics Market Segmentation by Product & Service (Assay Kits, Instruments, Services, and Consumables); by Tests (In-Vivo Tests and In-Vitro Tests); by Allergens (Inhaled Allergens, Food Allergens, Drug Allergens, and Others); and by End-Users (Diagnostic Laboratories, Hospital-Based Laboratories, Academic Research Institutes, and Others)-Global Demand Analysis & Opportunity Outlook 2031
Global Allergy Diagnostics Market Highlights Over 2022 - 2031
The global allergy diagnostics market generated a revenue figure of approximately USD 5.2 billion in the year 2021 and is expected to generate significant revenue towards the end of the year 2031, by growing at a CAGR of ~13% over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to the increasing prevalence of allergic diseases, developing healthcare infrastructures, and increasing disposable income. In addition, rising environmental pollution levels, supportive aids from organizations in allergy diagnostics, and improvement in healthcare insurance are anticipated to be the major factors contributing to the market growth. According to the Asthma and Allergy Foundation of America (AAFA), each year, over 50 million people experience various types of allergies causing it to be the 6th leading cause of chronic illness in the U.S.
CLICK TO DOWNLOAD A SAMPLE REPORT
An allergy is a reaction or hypersensitivity that is caused by the immune system when a body comes in the contact with any foreign substance. A trained professional conduct an allergy test to determine the presence of a foreign substance to which the immune might react in an affected body. There are different methods used for the detection of allergy such as biopsy and diagnostic test which is the most common form of test conducted in order to diagnose allergies.
The global allergy diagnostics market is segmented on the basis of product & service, tests, allergens, and end users. Based on allergens, the market is segmented into inhaled allergens, food allergens, drug allergens, and others. Among these segments, the inhaled allergens segment is expected to hold the largest market share during the forecast period by growing at a moderate CAGR. The growth of the inhaled allergens segment can be attributed to the increasing incidences of respiratory allergies such as asthma, growing demand for allergy testing, increasing environmental pollution, and rising cases of pollen allergy.
Global Allergy Diagnostics Market Regional Synopsis
Regionally, the global allergy diagnostics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in North America region witnessed a modest growth in the year 2021 on the account of increasing incidences of allergic diseases, environmental pollution, and the presence of key market players in the region. Additionally, the market in the Europe region also contributed moderately in the previous year. On the other hand, the market in the Asia Pacific region is estimated to hold the largest market share during the forecast period on the back of improvement in life sciences research and growing governmental initiatives to spread awareness about allergy diagnostics. Moreover, the growing geriatric population and rising incidences of allergic conditions are major factors contributing to the growth of the market. In the Asia Pacific region, food allergy accounts to the most common allergic disease which affects around 10% of the population in the region.
Market Segmentation
Our in-depth analysis of the global allergy diagnostics market includes the following segments:
By Product and Service
-
Assay Kits
-
Instruments
-
Services
-
Consumables
By Tests
-
In-Vivo Tests
-
In-Vitro Tests
By Allergens
-
Inhaled Allergens
-
Food Allergens
-
Drug Allergens
-
Others
By End Users
-
Diagnostic Laboratories
-
Hospital-Based Laboratories
-
Academic Research Institutes
-
Others
Growth Drivers and Challenges Impacting the Growth of the Global Allergy Diagnostics Market
Growth Drivers
-
Increasing cases of allergies
-
Rising level of environmental pollutions
-
Improving healthcare infrastructure
Challenges
-
High cost of diagnostic instruments
-
Lack of trained professionals
-
Lack of awareness about allergy-related diseases
Key Companies Dominating the Global Allergy Diagnostics Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global allergy diagnostics market that are included in our report are Allergy Therapeutics, Lincoln Diagnostics, Inc., Showa Denko Materials Co., Ltd., Demeditec Diagnostics GmbH, Danaher, Omega Diagnostics Group PLC, bioMérieux, Inc., HYCOR Biomedical, PerkinElmer, Inc. (EUROIMMUN Medizinische Labordiagnostika AG), Tecan Trading AG, THERADIAG, and others.
Latest Developments in the Global Allergy Diagnostics Market:
-
13 April 2021: Showa Denko Materials Co., Ltd. announced the transformation of Hitachi Chemical Diagnostics Systems Co., Ltd., a consolidated subsidiary of Showa Denko Materials to a fully owned subsidiary. The conversion will also include the acquisition of all common shares of HKDS that are owned by Kyowa Kirin Co., Ltd.
-
30 August 2021: Danaher Corporation, a global science, and technology innovator company, announced the completion of acquisition of Aldevron. Wherein, Danaher's Life Sciences segment will allow Aldevron to operate as a standalone operating company.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
- Allergy Therapeutics,
- Lincoln Diagnostics Inc.,
- Showa Denko Materials Co., Ltd.
- Demeditec Diagnostics GmbH
- Danaher
- Omega Diagnostics Group PLC
- bioMérieux Inc.,
- HYCOR Biomedical
- PerkinElmer Inc. (EUROIMMUN Medizinische Labordiagnostika AG)
- Tecan Trading AG
- THERADIAG
Related Reports
Study Period : 2023-2035
Report Format : PDF,PPT
Delivery Timeline : 48-72 Business Hours
Proof of Quality & Reliability
